CrushSCI.com
126.8Average days
114Median days
35Fastest days
308Longest days
2162025 publications

Paper Review Records

All Paper Review Records

16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

35 days

Ocular hyperemia with netarsudil/latanoprost fixed combination in glaucoma: an exploratory association analysis of tolerability outcomes by prior topical therapy and baseline ocular hyperemia

Authors
Gábor HollóShow moreShow less
Affiliations
1. Tutkimusz Ltd; 2. Prima Medica Health CentersShow moreShow less
Source PDF DOI Publisher page
60 days

A look into adverse renal effects of proton pump inhibitors

Authors
Marta Fernandez-Arquillue; Samuel J Martínez Domínguez; Ángel Lanas ArbeloaShow moreShow less
Affiliations
1. University of Zaragoza; 2. Hospital Clínico Universitario Lozano Blesa; 3. IIS Aragón (Instituto de Investigación Sanitaria Aragón); 4. Instituto de Salud Carlos IIIShow moreShow less
Source PDF DOI Publisher page
203 days

Long-term safety of treatment of hemophilia A: a comprehensive review

Authors
Johnny MahlanguShow moreShow less
Affiliations
1. University of the WitwatersrandShow moreShow less
Source PDF DOI Publisher page
137 days

Tolerance of methotrexate co-administered with pegloticase in patients with uncontrolled gout: overview of the findings from the mirror RCT

Authors
Vinicius Domingues; Abdul Abdellatif; Alexis Woods; Quinnie Yang; Michael E. Weinblatt; Junzhi Ji; Brad Marder; Brian LaMoreauxShow moreShow less
Affiliations
1. Florida State University; 2. Nephrology Division; 3. Amgen Inc; 4. Brigham and Women’s HospitalShow moreShow less
Source PDF DOI Publisher page
81 days

A safety review of JAK inhibitors for managing alopecia areata

Authors
Kanchalit Thanomkitti; Sofia Spagnolini; Antonella TostiShow moreShow less
Affiliations
1. Mahidol University; 2. University of Parma; 3. University of Miami Miller School of MedicineShow moreShow less
Source PDF DOI Publisher page
43 days

Psychedelics in psychiatry: comparative effectiveness, implementation, commercialization and safety lessons learned from intranasal esketamine

Authors
Roger S. McIntyreShow moreShow less
Affiliations
1. University of TorontoShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Expert Opinion On Drug Safety take to review a manuscript?

As of 2026-11-19, CrushSCI has 16 complete review records for Expert Opinion On Drug Safety. The fastest paper went from submission to acceptance in 35 days (Ocular hyperemia with netarsudil/latanoprost fixed combination in glaucoma: an exploratory association analysis of tolerability outcomes by prior topical therapy and baseline ocular hyperemia, received 2026-09-16, accepted 2026-10-21); the slowest took 308 days. The average is 126.8 days and the median is 114 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.